InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,001.12
(
0.47%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,994.81
(
0.61%
)
Brent Oil
73.73
(
-2.30%
)
Bitcoin
76,867.90
(
1.28%
)
Post# of 253559
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

imnot6

Send PM Follow Ignore
Followers 3
Posts 857
Boards Moderated 0
Alias Born 11/28/2005

imnot6

Member Level

Re: jbog post# 44286

Wednesday, 04/04/2007 9:56:20 AM

Wednesday, April 04, 2007 9:56:20 AM

Post# of 253559
"The toxicity profile seen with panitumumab was similar to that seen with Erbitux, [the FDA's] Hughes said...


...., noting that "the apparent lower incidence of infusion-related reactions may relate to how data were collected in the two applications."

Ouch!

(no pun intended)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up